Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2015 Publisher: Alliance Pharmaceuticals Limited, Avonbridge House, 2 Bath Road, Chippenham, Wiltshire, SN15 2BB, UK
Pharmacotherapeutic group: Wart and anticorn preparations
ATC code: D11AF
Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium. Salicylic acid is usually applied in the form of a paint in a collodian base (10 to 17%) or as a plaster (20 to 50%) to destroy warts or corns.
Salicylic acid may be percutaneously absorbed. However, there is no evidence of any systemic absorption from the use of Occlusal.
No other information relevant to the prescriber other than that already stated in other sections of the SPC.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
